Significantly decreased expression of SLC4A10 helps explain reduced cerebrospinal fluid (CSF) formation and turnover in Alzheimer’s disease (AD), resulting in impaired clearance of toxic metabolites and neuroinflammation [65]. Here, SLC4A10 is linked to Alzheimer disease.